MANNKIND CORP Payments to Acquire Short-term Investments
MANNKIND CORP (MNKD) reported Payments to Acquire Short-term Investments of $44.97 million for the 12-month period ending 2019-12-31, per its 10-K filed 2021-02-25.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2021-02-25
- MANNKIND CORP payments to acquire short-term investments for the quarter ending 2019-12-31 was $91.00K.
- MANNKIND CORP payments to acquire short-term investments for the quarter ending 2019-09-30 was $19.97M.
- MANNKIND CORP payments to acquire short-term investments for the quarter ending 2019-06-30 was $145.00K.
- MANNKIND CORP payments to acquire short-term investments for the quarter ending 2019-03-31 was $24.76M.
- MANNKIND CORP payments to acquire short-term investments for fiscal 2019 was $44.97M.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month |
|---|---|---|---|---|
| 2019-12-31 | $91.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $20.06M derived: sum of 2 quarters · filed 2021-02-25 | $20.21M derived: sum of 3 quarters · filed 2021-02-25 | $44.97M 10-K · filed 2021-02-25 |
| 2019-09-30 | $19.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $20.12M derived: sum of 2 quarters · filed 2020-11-04 | $44.88M 10-Q · filed 2020-11-04 | |
| 2019-06-30 | $145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $24.91M 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $24.76M 10-Q · filed 2020-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |